Nasogastric Tube (NGT) Indications, Timing, and Management

Primary Functions

NGTs are used for enteral feeding in patients who cannot maintain adequate oral intake and for gastric decompression in bowel obstruction or ileus. 1

Fine‑bore (5–8 Fr) NGTs are recommended for enteral feeding unless repeated gastric aspiration or high‑viscosity feeds/medications are required. 2
Unconscious patients who cannot protect the airway or swallow safely should receive NGT feeding. 2
Patients with swallowing disorders (e.g., stroke, multiple sclerosis, motor neurone disease, Parkinson’s disease, cerebral palsy) are candidates for NGT feeding. 4
Individuals with partial intestinal failure needing nutritional supplementation are indicated for NGT feeding. 2
Post‑operative patients who cannot tolerate oral intake, especially after major gastrointestinal surgery, benefit from early NGT feeding, which reduces infection rates and shortens hospital stay. 6
Uncomplicated pancreatitis can be managed with NGT‑delivered nutrition. 7
Selected cases of severe anorexia nervosa with profound malnutrition may require NGT feeding. 2

NGT decompression is employed for bowel obstruction to relieve gastric distension, although its routine use in small‑bowel obstruction without active emesis is controversial. 1
Gastric outlet obstruction or delayed gastric emptying warrants NGT decompression. 1
Post‑operative ileus may be managed with NGT decompression when specifically indicated. 1

Artificial nutrition via NGT should commence when oral intake is absent or expected to be absent for 5–7 days; earlier initiation is advised for malnourished patients. 2
Severely malnourished post‑operative patients: consider NGT within 1–2 days after surgery. 2
Moderately malnourished post‑operative patients: consider NGT within 3–5 days after surgery. 2
Normally nourished post‑operative patients: consider NGT within 7 days after surgery. 2

NGTs are appropriate for short‑term access up to 4–6 weeks; beyond this, gastrostomy or jejunostomy should be considered. 4
Long‑term NGTs should be replaced every 4–6 weeks, alternating nostrils to reduce complications. 2
If feeding is expected to exceed 4–6 weeks, percutaneous gastrostomy is recommended because NGTs frequently become dislodged and may deliver less of the prescribed nutrition. 4

Use fine‑bore (5–8 Fr) tubes for feeding to minimize nasal and esophageal irritation and to lower aspiration risk; large‑bore PVC tubes should be avoided. 8
Large‑bore tubes are reserved only for repeated gastric aspiration or administration of high‑viscosity feeds/medications. 2
Tube position must be confirmed with pH testing before each use; routine radiographs are not required for placement verification. 2

NGT insertion should be avoided for 3 days after acute variceal bleeding; if insertion is unavoidable, only fine‑bore tubes should be used. 2
Weighted NGTs provide no advantage for placement accuracy or tube maintenance. 2

NGT placement is a medical treatment that requires informed consent or a best‑interest determination for patients lacking decision‑making capacity, with full consultation of family and the healthcare team. 2
The decision to place an NGT must prioritize whether life‑prolongation aligns with the patient’s best interests. 2
In terminal illness with purely palliative goals, NGT feeding should be offered only to relieve symptoms, not to extend survival. 10